ProfileGDS5678 / 1448506_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 16% 16% 15% 15% 16% 15% 15% 15% 16% 16% 15% 16% 16% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4100716
GSM967853U87-EV human glioblastoma xenograft - Control 22.3815616
GSM967854U87-EV human glioblastoma xenograft - Control 32.3870316
GSM967855U87-EV human glioblastoma xenograft - Control 42.3284215
GSM967856U87-EV human glioblastoma xenograft - Control 52.3275315
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4394416
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4003615
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3615615
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3456615
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3724316
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3711916
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.348515
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3783216
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3788716